Background: Alzheimer’s disease (AD) is the most common neurodegenerative disease, severely reducing cognitive level and life quality of patients. Byu dMar 25 (BM25) has been proved to have a therapeutic effect on AD. However, pharmacological mechanism still unclear. Therefore, this study aims reveal potential BM25 affecting AD from perspective network pharmacology experimental validation. Meth...